Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 1
2021 5
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Reversal of malignant ADAR1 splice isoform switching with Rebecsinib.
Crews LA, Ma W, Ladel L, Pham J, Balaian L, Steel SK, Mondala PK, Diep RH, Wu CN, Mason CN, van der Werf I, Oliver I, Reynoso E, Pineda G, Whisenant TC, Wentworth P, La Clair JJ, Jiang Q, Burkart MD, Jamieson CHM. Crews LA, et al. Among authors: van der werf i. Cell Stem Cell. 2023 Mar 2;30(3):250-263.e6. doi: 10.1016/j.stem.2023.01.008. Epub 2023 Feb 16. Cell Stem Cell. 2023. PMID: 36803553 Free PMC article.
Detection and targeting of splicing deregulation in pediatric acute myeloid leukemia stem cells.
van der Werf I, Mondala PK, Steel SK, Balaian L, Ladel L, Mason CN, Diep RH, Pham J, Cloos J, Kaspers GJL, Chan WC, Mark A, La Clair JJ, Wentworth P, Fisch KM, Crews LA, Whisenant TC, Burkart MD, Donohoe ME, Jamieson CHM. van der Werf I, et al. Cell Rep Med. 2023 Mar 21;4(3):100962. doi: 10.1016/j.xcrm.2023.100962. Epub 2023 Mar 7. Cell Rep Med. 2023. PMID: 36889320 Free PMC article.
A multidimensional analysis reveals distinct immune phenotypes and tertiary lymphoid structure-like aggregates in the bone marrow of pediatric acute myeloid leukemia.
Koedijk JB, van der Werf I, Penter L, Vermeulen MA, Barneh F, Perzolli A, Meesters-Ensing JI, Fiocco M, de Groot-Kruseman HA, Moeniralam R, Christensen KB, Porter B, Pfaff K, Garcia JS, Rodig SJ, Wu CJ, Hasle H, Nierkens S, Belderbos ME, Zwaan CM, Heidenreich O. Koedijk JB, et al. Among authors: van der werf i. medRxiv [Preprint]. 2023 Oct 30:2023.03.03.23286485. doi: 10.1101/2023.03.03.23286485. medRxiv. 2023. PMID: 37961528 Free PMC article. Preprint.
Targeting Tumor Vascular CD99 Inhibits Tumor Growth.
Huijbers EJM, van der Werf IM, Faber LD, Sialino LD, van der Laan P, Holland HA, Cimpean AM, Thijssen VLJL, van Beijnum JR, Griffioen AW. Huijbers EJM, et al. Among authors: van der werf im. Front Immunol. 2019 Apr 2;10:651. doi: 10.3389/fimmu.2019.00651. eCollection 2019. Front Immunol. 2019. PMID: 31001265 Free PMC article.
SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia.
van der Werf I, Wojtuszkiewicz A, Yao H, Sciarrillo R, Meggendorfer M, Hutter S, Walter W, Janssen J, Kern W, Haferlach C, Haferlach T, Jansen G, Kaspers GJL, Groen R, Ossenkoppele G, Cloos J. van der Werf I, et al. Leukemia. 2021 Sep;35(9):2698-2702. doi: 10.1038/s41375-021-01273-7. Epub 2021 May 17. Leukemia. 2021. PMID: 34002025 Free PMC article. No abstract available.
Comprehensive single-cell genome analysis at nucleotide resolution using the PTA Analysis Toolbox.
Middelkamp S, Manders F, Peci F, van Roosmalen MJ, González DM, Bertrums EJM, van der Werf I, Derks LLM, Groenen NM, Verheul M, Trabut L, Pleguezuelos-Manzano C, Brandsma AM, Antoniou E, Reinhardt D, Bierings M, Belderbos ME, van Boxtel R. Middelkamp S, et al. Among authors: van der werf i. Cell Genom. 2023 Aug 23;3(9):100389. doi: 10.1016/j.xgen.2023.100389. eCollection 2023 Sep 13. Cell Genom. 2023. PMID: 37719152 Free PMC article.
Maturation State-Specific Alternative Splicing in FLT3-ITD and NPM1 Mutated AML.
Wojtuszkiewicz A, van der Werf I, Hutter S, Walter W, Baer C, Kern W, Janssen JJWM, Ossenkoppele GJ, Haferlach C, Cloos J, Haferlach T. Wojtuszkiewicz A, et al. Among authors: van der werf i. Cancers (Basel). 2021 Aug 4;13(16):3929. doi: 10.3390/cancers13163929. Cancers (Basel). 2021. PMID: 34439083 Free PMC article.
Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia.
van der Werf I, Wojtuszkiewicz A, Yao H, Sciarrillo R, Meggendorfer M, Hutter S, Walter W, Janssen J, Kern W, Haferlach C, Haferlach T, Jansen G, Kaspers GJL, Groen R, Ossenkoppele G, Cloos J. van der Werf I, et al. Leukemia. 2021 Sep;35(9):2735. doi: 10.1038/s41375-021-01340-z. Leukemia. 2021. PMID: 34272482 Free PMC article. No abstract available.
12 results